These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2523015)

  • 1. Central mu, delta, and kappa opioid binding sites, and brain and pituitary beta-endorphin and met-enkephalin in genetically obese (ob/ob) and lean mice.
    Khawaja XZ; Bailey CJ; Green IC
    Life Sci; 1989; 44(16):1097-105. PubMed ID: 2523015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.
    Timmers K; Voyles NR; Zalenski C; Wilkins S; Recant L
    Diabetes; 1986 Oct; 35(10):1143-51. PubMed ID: 2944783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
    Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
    Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the content of beta-endorphin and enkephalin-like peptides in the pituitary of obese (ob/ob) mice.
    Govoni S; Yang HY
    J Neurochem; 1981 May; 36(5):1829-33. PubMed ID: 6264037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.
    James IF; Chavkin C; Goldstein A
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7570-4. PubMed ID: 6130527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive beta-endorphin and met- and leu-enkephalin contents in pancreas and pituitary of corpulent (cp/cp) rats.
    Timmers K; Voyles NR; Wilkins S; Michaelis OE; Bhathena SJ; Recant L
    Int J Obes; 1989; 13(3):337-45. PubMed ID: 2527831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-endorphin and corticotropin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice.
    Hughes S; Smith ME; Bailey CJ
    Neuroscience; 1992; 48(2):463-8. PubMed ID: 1318515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential development of beta-endorphin and mu opioid binding sites in mouse brain.
    Barg J; Rius RA; Bem WT; Belcheva MM; Loh YP; Coscia CJ
    Brain Res Dev Brain Res; 1992 Mar; 66(1):71-6. PubMed ID: 1318173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A; Herz A
    Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice.
    Khawaja XZ; Chattopadhyay AK; Green IC
    Brain Res; 1991 Jul; 555(1):164-8. PubMed ID: 1681994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of 3H-beta-endorphin in rat brain.
    Johnson N; Houghten R; Pasternak GW
    Life Sci; 1982 Sep 20-27; 31(12-13):1381-4. PubMed ID: 6292632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain.
    Gillan MG; Kosterlitz HW
    Br J Pharmacol; 1982 Nov; 77(3):461-9. PubMed ID: 6291693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid activities of fragments of beta-endorphin and of its leucine65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin.
    Waterfield AA; Leslie FM; Lord JA; Ling N; Kosterlitz HW
    Eur J Pharmacol; 1979 Sep; 58(1):11-8. PubMed ID: 499333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the binding characteristics of tritiated opiates and opioid peptides.
    Gillan MG; Kosterlitz HW; Paterson SJ
    Br J Pharmacol; 1980 Nov; 70(3):481-90. PubMed ID: 7437652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.